Latest filing published 20 Aug 2021 for Eton Pharmaceuticals, Inc., €19k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
William Wilson Troutman: trading record in brief
All filings by William Wilson Troutman on record concern Eton Pharmaceuticals, Inc., in the capacity of finance chief. In total, 2 filings cover trades dated from 15 November 2018 to 20 August 2021.
Purchases make up the whole of the open-market record (2 purchases, €45k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2021 alone, the filings show 1 purchase and no sales.
Most recently, on 20 August 2021, the filings show an open-market purchase worth €19k in Eton Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Wilson Troutman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$4.43100.0% of flowCommon StockSEC:0001493152-21-020809:0Canonical exit: 18 Nov 2021 (T+90)
1 of 1 declaration
